[Results of a French retrospective study on autologous transfusion]

To determine organization of autotransfusion in France, two questionnaires were sent to blood centers, anesthetists in 2,100 public hospitals, 50 anesthetists in private clinics and members of the French Hemapheresis Society, requesting information on autotransfusion method, date of installation, applications and persons responsible for its use. Data collected showed wide use of autotransfusion in order to economise human products before any legislation and before pressure due to transfusion transmissible diseases (TTD). However, many groups began this activity in 1987, and others still hesitate because of practical difficulties (legislation, cost, liability) in spite of the request of their colleagues or patients motivated by the risk of TTD.